These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3467658)

  • 1. Subacute cutaneous lupus erythematosus in multiple members of a family with C2 deficiency.
    Callen JP; Hodge SJ; Kulick KB; Stelzer G; Buchino JJ
    Arch Dermatol; 1987 Jan; 123(1):66-70. PubMed ID: 3467658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency.
    Holtman JH; Neustadt DH; Klein J; Callen JP
    J Rheumatol; 1990 Sep; 17(9):1222-5. PubMed ID: 2290166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
    Provost TT; Watson R
    J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic studies in a family with heterozygous C2 deficiency.
    McCarty DJ; Tan EM; Zvaifler NJ; Koethe S; Duquesnoy RJ
    Am J Med; 1981 Dec; 71(6):945-8. PubMed ID: 6797295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus.
    Furukawa F; Muto M
    Arch Dermatol Res; 2009 Jan; 301(1):111-5. PubMed ID: 18797890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C2 deficient systemic lupus erythematosus: its association with anti-Ro (SSA) antibodies.
    Vandersteen PR; Provost TT; Jordon RE; McDuffie FC
    Arch Dermatol; 1982 Aug; 118(8):584-7. PubMed ID: 6980631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.
    Provost TT; Talal N; Bias W; Harley JB; Reichlin M; Alexander EL
    J Invest Dermatol; 1988 Oct; 91(4):369-71. PubMed ID: 3262691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
    López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
    Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.
    Meyer O; Hauptmann G; Tappeiner G; Ochs HD; Mascart-Lemone F
    Clin Exp Immunol; 1985 Dec; 62(3):678-84. PubMed ID: 3878757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA and genetic predisposition to lupus erythematosus and other dermatologic disorders.
    Arnett FC
    J Am Acad Dermatol; 1985 Sep; 13(3):472-81. PubMed ID: 3902918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
    Zappi E; Sontheimer R
    Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute cutaneous lupus erythematosus-immunogenetic associations.
    Watson RM; Talwar P; Alexander E; Bias WB; Provost TT
    J Autoimmun; 1991 Feb; 4(1):73-85. PubMed ID: 2031665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic deficiency of C2 associated with haplotype A25, B18 in familial systemic lupus erythematosus].
    Gantes MA; González T
    Med Clin (Barc); 1982 Oct 16-31; 79(7):295-8. PubMed ID: 7176738
    [No Abstract]   [Full Text] [Related]  

  • 14. U1RNP antibody-positive neonatal lupus. A report of two cases with immunogenetic studies.
    Dugan EM; Tunnessen WW; Honig PJ; Watson RM
    Arch Dermatol; 1992 Nov; 128(11):1490-4. PubMed ID: 1444503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody.
    Hamilton RG; Harley JB; Bias WB; Roebber M; Reichlin M; Hochberg MC; Arnett FC
    Arthritis Rheum; 1988 Apr; 31(4):496-505. PubMed ID: 2451920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus from the aspect of Japanese studies.
    Furukawa F; Yamamoto Y; Kanazawa N; Muto M
    Ann N Y Acad Sci; 2009 Sep; 1173():552-6. PubMed ID: 19758198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-Ro antibody system.
    Hymes SR; Russell TJ; Jordon RE
    Int J Dermatol; 1986; 25(1):1-7. PubMed ID: 3512458
    [No Abstract]   [Full Text] [Related]  

  • 18. Human Ro60 (SSA2) genomic organization and sequence alterations, examined in cutaneous lupus erythematosus.
    Millard TP; Ashton GH; Kondeatis E; Vaughan RW; Hughes GR; Khamashta MA; Hawk JL; McGregor JM; McGrath JA
    Br J Dermatol; 2002 Feb; 146(2):210-5. PubMed ID: 11903229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete deficiency in the C2 fraction of complement associated with a glomerular nephropathy: apropos of 2 cases].
    Ayed K; Bardi R; Sassi F; Gorgi Y; Ben Maiz H; Haddad S; Ben Ayed H
    Nephrologie; 1988; 9(5):239-44. PubMed ID: 3216945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement factor 2 deficiency: a clinical and serological family study.
    D'Cruz D; Taylor J; Ahmed T; Asherson R; Khamashta M; Hughes GR
    Ann Rheum Dis; 1992 Nov; 51(11):1254-6. PubMed ID: 1361318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.